NeueHealth(US:NEUE)2025-03-20 17:16Financial Data and Key Metrics Changes - In Q4 2024, NeueHealth reported consolidated revenue of $232.6 million, with full-year revenue reaching $936.7 million [15] - The gross margin for Q4 was $47.7 million, and for the full year, it was $194.5 million [15] - Adjusted EBITDA for Q4 was $5.5 million, with a total of $22.5 million for the full year, marking the fourth consecutive quarter of profitability [15] Business Line Data and Key Metrics Changes - In the NeueCare segment, Q4 revenue was $79.3 million, with full-year revenue at $313.7 million, and Q4 operating income was $9.2 million [16] - The NeueSolutions segment generated $157.1 million in revenue for Q4 and $635.1 million for the full year, with a Q4 operating income of $3.1 million but a full-year operating loss of $5.3 million [18] Market Data and Key Metrics Changes - NeueHealth served 483,000 consumers in 2024, reflecting a compound annual growth rate of 123% since 2020, and has grown to 717,000 consumers at the start of 2025, a 31% increase from 2024 [10][11] - The company expanded its consumer base in recently expanded markets by 97% [11] Company Strategy and Development Direction - NeueHealth aims to continue providing high-quality, affordable healthcare while diversifying the populations served across product categories [24] - The company plans to deepen its presence in local communities and expand into new geographies [24] - There is a focus on strengthening partnerships with payers and providers to enhance performance-based arrangements [25] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the company's ability to drive change in the healthcare industry and create a more coordinated experience for consumers, providers, and payers [26] - The company anticipates closing a transaction to be acquired by an affiliate of NEA in Q2 2025, which is expected to provide flexibility and resources for continued growth [12][13] Other Important Information - As of December 31, 2024, NeueHealth had $202.8 million in total cash and investments, with $93.2 million in nonregulated cash and short-term investments [20] Q&A Session Summary - No specific questions and answers were provided in the content, thus this section is not applicable.